|
ZNF585B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.550700E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.535550E-01 |
| Normal-vs-Stage2 |
3.330400E-02 |
| Normal-vs-Stage3 |
1.89962000000099E-05 |
| Normal-vs-Stage4 |
1.65179999678244E-08 |
| Stage1-vs-Stage2 |
1.854450E-01 |
| Stage1-vs-Stage3 |
2.247300E-04 |
| Stage1-vs-Stage4 |
3.08289999972899E-07 |
| Stage2-vs-Stage3 |
2.982800E-01 |
| Stage2-vs-Stage4 |
3.992200E-02 |
| Stage3-vs-Stage4 |
1.318360E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.629000E-04 |
| Normal-vs-AfricanAmerican |
1.054170E-02 |
| Normal-vs-Asian |
8.526800E-01 |
| Caucasian-vs-AfricanAmerican |
5.175200E-01 |
| Caucasian-vs-Asian |
2.165000E-01 |
| AfricanAmerican-vs-Asian |
2.126800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.000100E-04 |
| Normal-vs-Female |
9.601400E-03 |
| Male-vs-Female |
2.790000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.015600E-02 |
| Normal-vs-Age(41-60Yrs) |
4.680400E-02 |
| Normal-vs-Age(61-80Yrs) |
2.20079999999623E-05 |
| Normal-vs-Age(81-100Yrs) |
3.101400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.985800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.860800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.901400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.072190E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.388590E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.849400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.115200E-03 |
| Normal-vs-Grade 2 |
1.209250E-01 |
| Normal-vs-Grade 3 |
2.42239999999061E-05 |
| Normal-vs-Grade 4 |
5.83859960379129E-10 |
| Grade 1-vs-Grade 2 |
2.896900E-03 |
| Grade 1-vs-Grade 3 |
3.18190000003771E-06 |
| Grade 1-vs-Grade 4 |
3.5710000512168E-09 |
| Grade 2-vs-Grade 3 |
2.419100E-03 |
| Grade 2-vs-Grade 4 |
3.94850000473568E-08 |
| Grade 3-vs-Grade 4 |
2.403600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.741000E-01 |
| Normal-vs-ccB subtype |
1.53048000000044E-05 |
| ccA subtype-vs-ccB subtype |
6.11469999967085E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.971300E-04 |
| Normal-vs-N1 |
1.375710E-04 |
| N0-vs-N1 |
7.205600E-02 |
|
|
